NCT06741995View on ClinicalTrials.gov

Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 17, 2024

Primary Completion Date

December 17, 2027

Study Completion Date

December 17, 2027

Conditions
Dilated Cardiomyopathy (DCM)
Trial Locations (1)

430000

RECRUITING

Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER